Amphetamine‐induced release of dendritic dopamine in substantia nigra pars reticulata: D1‐mediated behavioral and electrophysiological effects

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Synapse

• Publication date

  1996-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/(SICI)1098-2396(199608)23:4<280::AID-SYN6>3.0.CO;2-3PMID 8855513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Behavioural effects mediated by unilateral nigral dopamine receptor stimulation in the rat

  2004cited by this paper
• Modulation of dopamine D1‐mediated turning behavior and striatal c‐fos expression by the substantia nigra

  1995cited by this paper
• Cortical lesions attenuate the opposing effects of amphetamine and haloperidol on neostriatal neurons in freely moving rats.

  1994cited by this paper
• Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model

  1994cited by this paper
• Basal ganglia GABAA and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in rat.

  1994cited by this paper
• The physiologically induced release of ascorbate in rat brain is dependent on impulse traffic, calcium influx and glutamate uptake.

  1994cited by this paper
• Dopamine D1 receptors facilitate transmitter release

  1993cited by this paper
• Intranigral injections of SCH 23390 inhibit amphetamine-induced rotational behavior.

  1993cited by this paper
• Unilateral neostriatal kainate, but not 6-OHDA, lesions block dopamine agonist-induced ascorbate release in the neostriatum of freely moving rats.

  1992cited by this paper
• Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity

  1992cited by this paper
• Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus

  1991cited by this paper
• Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats

  1991cited by this paper
• Bilateral alterations in local cerebral glucose utilization following intranigral application of the GABAergic agonist muscimol

  1990cited by this paper
• Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum.

  1990cited by this paper
• Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.

  1990cited by this paper
• Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.

  1990cited by this paper
• Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat.

  1990cited by this paper
• Disinhibition as a basic process in the expression of striatal functions.

  1990cited by this paper
• Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms

  1989cited by this paper
• Factors that predict individual vulnerability to amphetamine self-administration.

  1989cited by this paper
• Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine.

  1989cited by this paper
• Differential Effect of Stress on In Vivo Dopamine Release in Striatum, Nucleus Accumbens, and Medial Frontal Cortex

  1989cited by this paper
• The D1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand.

  1988cited by this paper
• Immunocytochemical demonstration of GABAergic synaptic connections in rat substantia nigra after different lesions of the striatonigral projection.

  1988cited by this paper
• Serotonergic component of SCH 23390: in vitro and in vivo binding analyses.

  1988cited by this paper
• Amphetamine-induced increase in motor activity is correlated with higher firing rates of non-dopamine neurons in substantia nigra and ventral tegmental area.

  1988cited by this paper
• Rotation following intranigral injections of a selective D1 or a selective D2 dopamine receptor agonist in rats.

  1988cited by this paper
• Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine.

  1988cited by this paper
• Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behaviour in the rabbit.

  1987cited by this paper
• Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?

  1987cited by this paper
• Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4‐dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats

  1987cited by this paper
• The role of dopamine released from distal and proximal dendrites of nigrostriatal dopaminergic neurons in the control of GABA transmission in the thalamic nucleus ventralis medialis in the cat.

  1987cited by this paper
• Stress-induced insomnia: opioid-dopamine interactions.

  1987cited by this paper
• Topography of substantia nigra innervation by D1 receptor-containing striatal neurons.

  1987cited by this paper
• Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.

  1987cited by this paper
• Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.

  1987cited by this paper
• The effects of cortical ablation on multiple unit activity in the striatum following dexamphetamine.

  1987cited by this paper
• Activity of pars reticulata neurons of monkey substantia nigra in relation to motor, sensory, and complex events.

  1986cited by this paper
• Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum.

  1986cited by this paper
• 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine.

  1986cited by this paper
• Endogenous dopamine can modulate inhibition of substantia nigra pars reticulata neurons elicited by GABA iontophoresis or striatal stimulation

  1986cited by this paper
• Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.

  1986cited by this paper
• Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain

  1986cited by this paper
• Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.

  1986cited by this paper
• Evidence for a functional role of dopamine type-1 (D-1) receptors in the substantia nigra of rats.

  1986cited by this paper
• Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.

  1985cited by this paper
• Stimulation of dopamine D-1 receptors by SKF 38393 induces EEG desynchronization and behavioral arousal.

  1985cited by this paper
• Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.

  1985cited by this paper
• GABA axons in synaptic contact with dopamine neurons in the substantia nigra: double immunocytochemistry with biotin-peroxidase and protein A-colloidal gold.

  1985cited by this paper
• The striatonigral projection and nigrotectal neurons in the rat. A correlated light and electron microscopic study demonstrating a monosynaptic striatal input to identified nigrotectal neurons using a combined degeneration and horseradish peroxidase procedure.

  1985cited by this paper
• Systemic and nigral application of amphetamine both cause an increase in extracellular concentration of ascorbate in the caudate nucleus of the rat.

  1985cited by this paper
• Disinhibition as a basic process in the expression of striatal functions. II. The striato-nigral influence on thalamocortical cells of the ventromedial thalamic nucleus.

  1985cited by this paper
• Effect of dopamine system activation on substantia nigra pars reticulata output neurons: variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned rats

  1984cited by this paper
• Immobilization of rats modifies the response of striatal neurons to dexamphetamine.

  1984cited by this paper
• Evidence that striatal efferents relate to different dopamine receptors.

  1984cited by this paper
• Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390.

  1984cited by this paper
• Role of nigral dopamine in amphetamine-induced locomotor activity.

  1983cited by this paper
• Visual and oculomotor functions of monkey substantia nigra pars reticulata. IV. Relation of substantia nigra to superior colliculus.

  1983cited by this paper
• Interactions between dopamine and gamma-aminobutyrate in the substantia nigra: implications for the striatonigral output hypothesis.

  1983cited by this paper
• Dopamine modulation of the effects of gamma-aminobutyric acid on substantia nigra pars reticulata neurons.

  1983cited by this paper
• Nigral dopaminergic mechanisms in drug-induced circling.

  1983cited by this paper
• Neuronal interactions in the substantia nigra pars reticulata through axon collaterals of the projection neurons

  1982cited by this paper
• Crossed connections of the substantia nigra in the rat

  1982cited by this paper
• Morphology of the substantia nigra pars reticulata projection neurons intracellularly labeled with HRP

  1982cited by this paper
• Turning behaviour following nigral injections of dopamine agonists and glycine.

  1982cited by this paper
• Involvement of dopamine in circling responses to muscimol depends on intranigral site of injection.

  1981cited by this paper
• Dendritic release of dopamine in the substantia nigra

  1981cited by this paper
• Dopaminergic activation of reticulata neurones in the substantia nigra

  1980cited by this paper
• Behavioural effects and supersensitivity following nigral dopamine receptor stimulation

  1980cited by this paper
• Lesions of substantia nigra by kainic acid: effects on apomorphine-induced stereotyped behaviour.

  1980cited by this paper
• The afferent and efferent connections of the ventromedial thalamic nucleus in the rat

  1979cited by this paper
• Evidence for a gabaergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat

  1979cited by this paper
• Behavioral differences induced by muscimol selectively injected into pars compacta and pars reticulata of Substantia Nigra

  1979cited by this paper
• Dexamphetamine increases striatal neuronal firing in freely moving rats.

  1979cited by this paper
• Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation.

  1978cited by this paper
• The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.

  1978cited by this paper
• Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra.

  1978cited by this paper
• The cells of origin of nigrotectal, nigrothalamic and nigrostriatal projections in the rat.

  1978cited by this paper
• Dopamine concentrations in the rat brain following injections into the substantia nigra of baclofen, gamma-aminobutyric acid, gamma-hydroxybutyric acid, apomorphine and amphetamine.

  1978cited by this paper
• Function of nigral dopamine receptors?

  1978cited by this paper
• Striatal efferent fibers play a role in maintaining rotational behavior in the rat

  1977cited by this paper
• Feedback loop or output pathway in striato-nigral fibres?

  1977cited by this paper
• Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro

  1977cited by this paper
• Nigral and striatal dopamine release under sensory stimuli

  1977cited by this paper
• The substantia nigra of the rat: A golgi study

  1977cited by this paper
• Striatal evoked inhibition of identified nigro-thalamic neurons.

  1976cited by this paper
• Evidence for the existence of a raphe projection to the substantia nigra in rat.

  1976cited by this paper
• Amphetamine-induced release of dopamine from the substantia nigra in vitro.

  1976cited by this paper
• Release of dopamine from dendrites in rat substantia nigra

  1976cited by this paper
• Dopamine release in substantia nigra?

  1976cited by this paper
• Apparent feedback from the caudate nucleus to the substantia nigra following amphetamine administration.

  1975cited by this paper
• AXONAL TRANSPORT IN NIGRO‐STRIATAL AND NIGRO‐THALAMIC NEURONS: EFFECTS OF MEDIAL FOREBRAIN BUNDLE LESIONS AND 6‐HYDROXYDOPAMINE 1

  1972cited by this paper

• Clustering Cortical Rhythms: Monoaminergic Signatures in Time-Frequency EEG Dynamics

  2025cites this paper
• Characterization of Gαs and Gαolf activation by catechol and non-catechol dopamine D1 receptor agonists

  2024cites this paper
• Altered parabrachial nucleus nociceptive processing may underlie central pain in Parkinson’s disease

  2023cites this paper
• Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats

  2021cites this paper
• Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease.

  2019cites this paper
• Investigating the effects of chronic amphetamine treatment on the midbrain superior colliculus

  2018cites this paper
• Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification.

  2017cites this paper
• The effects of dexamphetamine on the resting state EEG and functional connectivity

  2017influential citation
• The effects of dexamphetamine on the resting‐state electroencephalogram and functional connectivity

  2016influential citation
• Explorer Dendritic release of neurotransmitters

  2016cites this paper
• Dendritic Release of Neurotransmitters.

  2016cites this paper
• Somatodendritic dopamine release: recent mechanistic insights

  2015cites this paper
• 5-HT1A receptor-dependent control of nigrostriatal dopamine neurotransmission in the pharmacotherapy of Parkinson's disease and schizophrenia.

  2015cites this paper
• Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.

  2013cites this paper
• Neurocircuitry for modeling drug effects

  2012cites this paper
• Dopamine release in the basal ganglia.

  2011cites this paper
• The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.

  2011cites this paper
• Ultrastructural localization and function of dopamine D1‐like receptors in the substantia nigra pars reticulata and the internal segment of the globus pallidus of parkinsonian monkeys

  2010cites this paper
• Synaptic Plasticity in Basal Ganglia Output Neurons in Parkinson's Disease Patients

  2010cites this paper
• Extrastriatal Dopaminergic Circuits of the Basal Ganglia

  2010cites this paper
• Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease.

  2010cites this paper
• The brain pattern of c-fos induction by two doses of amphetamine suggests different brain processing pathways and minor contribution of behavioural traits.

  2010cites this paper
• Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.

  2009cites this paper
• Comparative Ultrastructural Analysis of D1 and D5 Dopamine Receptor Distribution in the Substantia Nigra and Globus Pallidus of Monkeys.

  2009cites this paper
• Dopamine and the regulation of movements - significance of nigral and striatal dopamine release in normal, hemiparkinsonian and dyskinetic rats

  2009cites this paper
• Diadenosine tetraphosphate reduces toxicity caused by high-dose methamphetamine administration.

  2009cites this paper
• Mobilization of Calcium from Intracellular Stores Facilitates Somatodendritic Dopamine Release

  2009cites this paper
• Striatal and extrastriatal dopamine in the basal ganglia: An overview of its anatomical organization in normal and Parkinsonian brains

  2008cites this paper
• Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway.

  2008cites this paper
• Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys.

  2007influential citation
• The pars reticulata of the substantia nigra: a window to basal ganglia output.

  2007cites this paper
• Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission

  2006cites this paper
• Dopamine action in the substantia nigra pars reticulata: iontophoretic studies in awake, unrestrained rats

  2006influential citation
• Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice.

  2006cites this paper
• Limited regulation of somatodendritic dopamine release by voltage‐sensitive Ca2+ channels contrasted with strong regulation of axonal dopamine release

  2006cites this paper
• Cell replacement efforts to repair neuronal injury: A potential paradigm for the treatment of Parkinson's disease

  2005cites this paper
• Somatodendritic Dopamine Release in Midbrain

  2005cites this paper
• Dopamine Release in Substantia Nigra: Release Mechanisms and Physiological Function in Motor Control

  2005cites this paper
• [The effects of lesions in the compact part of the substantia nigra on glutamate and GABA release in the pedunculopontine nucleus].

  2005cites this paper
• The GABA uptake inhibitor β-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis

  2004cites this paper
• Neophobia and cortical and subcortical binding of the dopamine D2 receptor antagonist [3H]-raclopride.

  2004cites this paper
• High-Dose Methamphetamine Acutely Activates the Striatonigral Pathway to Increase Striatal Glutamate and Mediate Long-Term Dopamine Toxicity

  2004cites this paper
• Abundance and location of DARPP-32 in striato-tegmental circuits of domestic chicks.

  2004cites this paper
• Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra

  2004cites this paper
• Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.

  2003cites this paper
• Striatal dopaminergic stimulation produces c-Fos expression in the PPT and an increase in wakefulness.

  2003cites this paper
• Substantia nigra pars reticulata GABA is involved in the regulation of operant lever pressing: pharmacological and microdialysis studies.

  2003cites this paper
• Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra.

  2003cites this paper
• Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra

  2003cites this paper
• Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine.

  2003cites this paper
• Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod.

  2003cites this paper
• Dual Cholinergic Control of Fast-Spiking Interneurons in the Neostriatum

  2002cites this paper
• Afferent Control of Nigral Dopaminergic Neurons

  2002cites this paper
• Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area

  2002cites this paper
• Changes in somatodendritic but not terminal dopamine
regulation in aged rhesus monkeys

  2002cites this paper
• The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP‐treated and levodopa‐primed common marmosets

  2002cites this paper
• AFFERENT CONTROL OF NIGRAL DOPAMINERGIC NEURONS The role of GABAergic inputs

  2002cites this paper
• Distinct Roles for Nigral GABA and Glutamate Receptors in the Regulation of Dendritic Dopamine Release under Normal Conditions and in Response to Systemic Haloperidol

  2002cites this paper
• Novel Ca2+ Dependence and Time Course of Somatodendritic Dopamine Release: Substantia Nigra versus Striatum

  2001cites this paper
• Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat

  2001cites this paper
• Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: a dual-probe microdialysis study in intact conscious rat brain.

  2001cites this paper
• Interactions between dopamine D1 receptors and γ-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies

  2001cites this paper
• Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.

  2000cites this paper
• Substantia nigra pars reticulata lesion induces preconvulsive behavior and changes in glutamate receptor gene expression in the rat brain.

  2000cites this paper
• Locomotor activity and a conditioned fear response: correlation with cortical and subcortical binding of the dopamine D1 receptor antagonist [3H]SCH 23390

  2000cites this paper
• Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum: an in vivo microdialysis study.

  2000cites this paper
• Behavior-related changes in the activity of substantia nigra pars reticulata neurons in freely moving rats.

  1999cites this paper
• GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.

  1999cites this paper
• Dopaminergic input is required for increases in serotonin output produced by behavioral activation: an in vivo microdialysis study in rat forebrain.

  1999cites this paper
• Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine.

  1999cites this paper
• Behavioral changes associated with grafts of embryonic ventral mesencephalon tissue into the striatum and/or substantia nigra in a rat model of Parkinson's Disease.

  1999cites this paper
• The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.

  1999cites this paper
• Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats

  1999cites this paper
• Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata

  1998cites this paper
• Biotransformation of l‐DOPA to Dopamine in the Substantia Nigra of Freely Moving Rats: Effect of Dopamine Receptor Agonists and Antagonists

  1998cites this paper
• [Transplantation of fetal dopaminergic cells simultaneously to the corpus striatum and pars reticularis of the substantia nigra in hemi-parkinsonian rats].

  1998cites this paper
• Tremulous jaw movements in rats: a model of parkinsonian tremor.

  1998cites this paper
• N‐methyl‐D‐aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra

  1998cites this paper
• Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine.

  1997cites this paper
• 3‐Methoxytyramine Formation Following Monoamine Oxidase Inhibition Is a Poor Index of Dendritic Dopamine Release in the Substantia Nigra

  1997cites this paper
• Behavioral and Neurochemical Recovery from Partial 6-Hydroxydopamine Lesions of the Substantia Nigra Is Blocked by Daily Treatment with D1/D5, But Not D2, Dopamine Receptor Antagonists

  1997cites this paper
• Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo.

  1997cites this paper
• Substantia Nigra D1 Receptors and Stimulation of Striatal Cholinergic Interneurons by Dopamine: A Proposed Circuit Mechanism

  1997cites this paper
• A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine.

  1996cites this paper